C-PHRM

C:PHRM - PharmaTher Holdings Ltd. - http://www.pharmather.com

10:56:22 EDT

Sym-X	Bid - Ask					Last	Chg	%Ch	Vol	$Vol	#Tr	Open-Hi-Lo	Year Hi-Lo	Last Tr	News	Delay
PHRM - C	8.5	0.215	·	0.245	2.0	0.23	+0.01	4.5	89.9	19	26	0.215 0.23 0.215	0.43 0.08	15:59:59	May 15	15 min RT 2¢
CSE - C	8.5	0.215	·	0.245	2.0	0.215	-0.005	-2.3	14.0	3	8	0.215 0.225 0.215	0.43 0.08	15:22:58		15 min
NEO ATS - U						0.22			4.0	1	4	0.22 0.22 0.22		13:19:57		15 min
Omega - O						0.215	-0.005	-2.3	50.0	11	7	0.23 0.23 0.215		14:45:32		15 min
Chi-X - X						0.22			0.5	0	1	0.22 0.22 0.22		10:37:46		15 min
CX2 - H						0.23	+0.01	4.5	21.0	5	4	0.22 0.23 0.22		15:59:59		15 min
CXD - D						0.22			0.1		1			Apr 10		15 min
TriAct - M						0.22			0.3		1					15 min

Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
NOTE: Delayed ATS trade data is included - click System Status for more information

Hide ATS · Fundamentals · Holders · Trade Workstation · Market Depth · 3 Month Closes · Technical Charts 1 yr | 2 yr | 3 yr | 5 yr | 10 yr | 15 yr | 20 yr · Live Charts 1 yr | 1 day · Company · Participants · 1yr Bulletins · Sedar · Historical · Shorts · Portfolio

Recent Trades - Last 10 of 26

More trades...

Time ET	Ex	Price	Change	Volume	Buyer	Seller	Markers
15:59:59	H	0.23	0.01	1,500	79 CIBC	1 Anonymous	K
15:22:58	C	0.215	-0.005	4,000	79 CIBC	79 CIBC	K
14:45:32	O	0.215	-0.005	1,500	1 Anonymous	2 RBC	K
13:19:57	U	0.22		500	1 Anonymous	2 RBC	K
13:19:57	U	0.22		500	1 Anonymous	2 RBC	K
13:19:57	U	0.22		500	1 Anonymous	2 RBC	K
13:19:57	O	0.22		12,000	1 Anonymous	39 Merrill Lynch	K
13:19:57	H	0.22		18,000	1 Anonymous	39 Merrill Lynch	K
13:19:57	D	0.225	0.005	100	7 TD Sec	39 Merrill Lynch	E
13:19:57	C	0.225	0.005	1,000	1 Anonymous	39 Merrill Lynch	K

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Date ET	Symbol	Price	Type	Headline
2024-05-15 14:20	C:PHRM	0.22	News Release200	Pharmather's Sairiyo applies for cepharanthine study
2024-05-10 10:42	C:PHRM	0.30	News Release200	Pharmather assigned Oct. 29 FDA OK goal date for ANDA
2024-05-01 13:37	C:PHRM	0.275	News Release200	Pharmather, Pharmadrug complete PD-001 clinical package
2024-04-23 02:12	C:PHRM	0.215	SEDAR Interim MD & A813	SEDAR Interim MD & A
2024-04-23 02:11	C:PHRM	0.215	SEDAR Interim Financial Statements812	SEDAR Interim Financial Statements
2024-04-18 16:10	C:PHRM	0.23	News Release200	Pharmather receives complete response for ketamine ANDA
2024-04-16 14:03	C:PHRM	0.21	News Release200	Pharmather hopes to submit ketamine responses this week
2024-04-02 11:21	C:PHRM	0.385	News Release200	Revive clinical study enrolls nearly 50% of sample
2024-02-21 13:19	C:PHRM	0.21	News Release200	Pharmather, Pharmadrug begin Sairiyo plan for PD-001
2024-02-14 13:15	C:PHRM	0.225	News Release200	Pharmadrug unit to manufacture PD-001 for human studies
2024-02-12 11:12	C:PHRM	0.19	News Release200	Pharmather talks ketamine ANDA, possible deficiencies
2024-01-10 11:21	C:PHRM	0.225	News Release200	Pharmather expects FDA ketamine approval April 29, 2024
2023-10-30 19:15	C:PHRM	0.135	SEDAR Interim Financial Statements812	SEDAR Interim Financial Statements
2023-10-30 19:15	C:PHRM	0.135	SEDAR Interim MD & A813	SEDAR Interim MD & A
2023-09-28 18:20	C:PHRM	0.14	SEDAR Audited Annual Financial Statements804	SEDAR Audited Annual Financial Statements
2023-09-27 10:36	C:PHRM	0.15	News Release200	Pharmather's Ketarx drug application accepted by FDA
2023-09-06 10:38	C:PHRM	0.14	News Release200	Pharmather submits new drug application for Ketarx
2023-07-18 10:06	C:PHRM		News Release200	Pharmather completes PharmaPatch research study
2023-06-27 12:05	C:PHRM	0.15	News Release200	Pharmather files presubmission facility correspondence
2023-06-20 07:51	C:PHRM	0.105	News Release200	Pharmather, Vitruvias to collaborate for Ketarx

Date ET

Symbol

Price

Type

Headline

2024-05-15 14:20

C:PHRM

0.22

News Release

Pharmather's Sairiyo applies for cepharanthine study

2024-05-10 10:42

C:PHRM